India, March 15 -- GLP-1 receptor agonists have gained attention as medications to manage type 2 diabetes and obesity. Drugs such as semaglutide and tirzepatide help regulate blood sugar and reduce appetite, which can lead to significant weight loss. Due of their effectiveness, many patients now use these medications as part of long-term treatment plans. However, experts caution that while GLP-1 medicines support weight management, they may also affect eating patterns and overall nutrition. When appetite drops, people may unintentionally consume fewer nutrients than their body needs.

According to Dr Shyam Sundar C M, Consultant Endocrinology and Diabetology, SPARSH Hospital, maintaining balanced nutrition is an essential part of safe an...